▼ PLUNGE

Eterna Therapeutics Inc.

-22.3%
ERNANASDAQHealthcare2026-04-30
0.148
종가
0.19
전일 종가
-22.32%
변동률
15.2x
거래량 비율

급락 원인

관련 뉴스가 없습니다.

관련 뉴스

Enanta Pharmaceuticals Announces First Participant Dosed in Phase 1 Clinical Trial of EDP-978, an Oral, Once-Daily KIT Inhibitor, in Development for the Treatment of Urticaria
Weeklyvoice2026-04-13
Neumora lines up April 13 Needham healthcare conference webcast
Stocktitan2026-04-06
Neumora Therapeutics to Participate in 25th Annual Needham Virtu
Gurufocus2026-04-06
NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Labeling Alignment for NRx’s Preservative-Free Ketamine Application
Weeklyvoice2026-04-06
Metagenomi Therapeutics, Inc. Announces Publication in Nature Structural & Molecular ...
Postregister2026-04-16

기술적 분석

시그널
볼린저 하단 돌파과매도MACD 약세SMA20 아래
주요 지표
24.14RSI (14)
0.20SMA 20
0.17Bollinger Lower
0.23Bollinger Upper
0.20Bollinger Mid
-0.02MACD
-0.02MACD Signal
0.00MACD Hist
종목 상세 보기급등주 목록으로
Eterna Therapeutics Inc. +-22.3% 급등 분석 (2026-04-30) | Alpha Lenz